Literature DB >> 20405276

[Prostatic inflammation and prostate cancer].

P J Bastian1, P Nuhn, T C Stadler, A Roosen, C G Stief.   

Abstract

Chronic inflammation seems of importance in multiple types of cancer. Numerous reports have revealed a potential link between chronic prostatatic inflammation and prostate cancer. The aim of this paper is to review the epidemiological, moprphological, molecular and clinical aspects of prostattic inflammation and prostate cancer.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20405276     DOI： 10.1007/s00120-010-2254-3

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  13 in total

Review 1.  Prostate cancer.

Authors:  William G Nelson; Angelo M De Marzo; William B Isaacs
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

2.  Epidemiologic association between prostatitis and prostate cancer.

Authors:  Leslie K Dennis; Charles F Lynch; James C Torner
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

Review 3.  The causes and prevention of cancer.

Authors:  B N Ames; L S Gold; W C Willett
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

4.  Correlates and prevalence of prostatitis in a large community-based cohort of older men.

Authors:  Nicholas A Daniels; Susan K Ewing; Joseph M Zmuda; Timothy J Wilt; Douglas C Bauer
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

Review 5.  Inflammation in prostate carcinogenesis.

Authors:  Angelo M De Marzo; Elizabeth A Platz; Siobhan Sutcliffe; Jianfeng Xu; Henrik Grönberg; Charles G Drake; Yasutomo Nakai; William B Isaacs; William G Nelson
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

6.  Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?

Authors:  R Shah; N R Mucci; A Amin; J A Macoska; M A Rubin
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

7.  Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index.

Authors:  J C Nickel; J Downey; D Hunter; J Clark
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

Review 8.  Insignificant prostate cancer and active surveillance: from definition to clinical implications.

Authors:  Patrick J Bastian; Ballentine H Carter; Anders Bjartell; Michael Seitz; Peter Stanislaus; Francesco Montorsi; Christian G Stief; Fritz Schröder
Journal:  Eur Urol       Date:  2009-03-06       Impact factor: 20.096

Review 9.  Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.

Authors:  Aditya Bardia; Elizabeth A Platz; Srinivasan Yegnasubramanian; Angelo M De Marzo; William G Nelson
Journal:  Curr Opin Pharmacol       Date:  2009-07-01       Impact factor: 5.547

Review 10.  Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.

Authors:  Patrick J Bastian; Srinivasan Yegnasubramanian; Ganesh S Palapattu; Craig G Rogers; Xiaohui Lin; Angelo M De Marzo; William G Nelson
Journal:  Eur Urol       Date:  2004-12       Impact factor: 20.096
View more
  1 in total

1.  A novel method to identify and isolate proliferative inflammatory atrophy (PIA) clusters and to extract high-quality PIA RNA.

Authors:  Yibing Wang; Chao Hao; Bin Fu; Weipeng Liu; Xiaocheng Zhou; Tao Zeng; Ju Guo; Gongxian Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.